Last reviewed · How we verify
Vaccination with Fluval AB Novo
Vaccination with Fluval AB Novo is a Biologic drug developed by Fluart Innovative Vaccine Ltd, Hungary. It is currently in Phase 1 development. Also known as: Fluval AB Novo, FL-K-13/09.
At a glance
| Generic name | Vaccination with Fluval AB Novo |
|---|---|
| Also known as | Fluval AB Novo, FL-K-13/09 |
| Sponsor | Fluart Innovative Vaccine Ltd, Hungary |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents (PHASE3)
- Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vaccination with Fluval AB Novo CI brief — competitive landscape report
- Vaccination with Fluval AB Novo updates RSS · CI watch RSS
- Fluart Innovative Vaccine Ltd, Hungary portfolio CI
Frequently asked questions about Vaccination with Fluval AB Novo
What is Vaccination with Fluval AB Novo?
Vaccination with Fluval AB Novo is a Biologic drug developed by Fluart Innovative Vaccine Ltd, Hungary.
Who makes Vaccination with Fluval AB Novo?
Vaccination with Fluval AB Novo is developed by Fluart Innovative Vaccine Ltd, Hungary (see full Fluart Innovative Vaccine Ltd, Hungary pipeline at /company/fluart-innovative-vaccine-ltd-hungary).
Is Vaccination with Fluval AB Novo also known as anything else?
Vaccination with Fluval AB Novo is also known as Fluval AB Novo, FL-K-13/09.
What development phase is Vaccination with Fluval AB Novo in?
Vaccination with Fluval AB Novo is in Phase 1.
Related
- Manufacturer: Fluart Innovative Vaccine Ltd, Hungary — full pipeline
- Also known as: Fluval AB Novo, FL-K-13/09